Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$5.94 USD
-0.04 (-0.67%)
Updated May 9, 2024 04:00 PM ET
After-Market: $5.98 +0.04 (0.67%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/02/2024
Time: -- |
6/2024 | $-0.60 | 8.77% |
Earnings Summary
For their last quarter, Foghorn Therapeutics (FHTX) reported earnings of -$0.59 per share, missing the Zacks Consensus Estimate of -$0.55 per share. This reflects a negative earnings surprise of 7.27%. Look out for FHTX's next earnings release expected on August 02, 2024. For the next earning release, we expect the company to report earnings of -$0.60 per share, reflecting a year-over-year increase of 14.29%.
Earnings History
Price & Consensus
Zacks News for FHTX
Does Foghorn Therapeutics (FHTX) Have the Potential to Rally 105.75% as Wall Street Analysts Expect?
FHTX: What are Zacks experts saying now?
Zacks Private Portfolio Services